Hemab Therapeutics Holdings, Inc.
COAG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002114044
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 20266:24 PM ET | Jun 15 – Jun 16, 2026 | RA Capital Healthcare Fund LP and 3 others10% Owner | PPurchaseCommon Stock | +67.67K | $24.9718 | +$1.69M | 6.44M | +1.1% | SEC |
| May 21, 20264:20 PM ET | May 19 – May 20, 2026 | RA Capital Healthcare Fund LP and 3 others10% Owner | PPurchaseCommon Stock | +4.8K | $24.9638 | +$119.78K | 6.38M | +0.1% | SEC |
| May 14, 20265:21 PM ET | May 12, 2026 | RA Capital Healthcare Fund LP and 3 others10% Owner | PPurchaseCommon Stock | +6.39K | $24.90 | +$159.04K | 6.37M | +0.1% | SEC |
| May 11, 20265:44 PM ET | May 7 – May 11, 2026 | RA Capital Healthcare Fund LP and 3 others10% Owner | PPurchaseCommon Stock | +51.26K | $24.7492 | +$1.27M | 6.37M | +0.8% | SEC |
| May 6, 20267:16 PM ET | May 4 – May 6, 2026 | RA Capital Healthcare Fund LP and 5 othersDirector, 10% Owner | PPurchaseCommon Stock | +2.84M | $18.3856 | +$52.22M | 6.31M | +81.8% | SEC |